408
Views
4
CrossRef citations to date
0
Altmetric
Author's View

Imatinib mesylate can help to direct natural immunity toward an anti-leukemic reactivity by acting on the bone marrow microenvironment

&
Pages 214-216 | Published online: 01 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Anna Kreutzman, Mette Ilander, Kimmo Porkka, Jukka Vakkila & Satu Mustjoki. (2014) Dasatinib promotes Th1-type responses in granzyme B expressing T-cells. OncoImmunology 3:5.
Read now
Erika Vacchelli, Nicole Prada, Oliver Kepp & Lorenzo Galluzzi. (2013) Current trends of anticancer immunochemotherapy. OncoImmunology 2:6.
Read now

Articles from other publishers (2)

Beata Ujvari, Rodrigo Hamede, Sarah Peck, David Pemberton, Menna Jones, Katherine Belov & Thomas Madsen. (2016) Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii). Scientific Reports 6:1.
Crossref
Bassam Francis Matti, Maysoon Ali Saleem & Shahla’a Fadhil Sabir. (2014) Assessment of Interleukin 1β Serum Level in Different Responder Groups and Stages of Chronic Myeloid Leukemia Patients on Imatinb Mesylate Therapy. Indian Journal of Hematology and Blood Transfusion 30:4, pages 247-252.
Crossref